ASX - By Stock
|
PIQ |
Re:
PIQ: IPO update
|
|
pezzstocks
|
37 |
13K |
0 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
37
|
13K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Value Projections
|
|
pezzstocks
|
41 |
12K |
0 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
41
|
12K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Value Projections
|
|
pezzstocks
|
41 |
12K |
4 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
41
|
12K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Suspension from Quotation
|
|
pezzstocks
|
5 |
2.8K |
4 |
23/09/23 |
23/09/23 |
ASX - By Stock
|
5
|
2.8K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
pezzstocks
|
19 |
7.3K |
6 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
19
|
7.3K
|
6
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Unique panel of biomarkers identified for oesophageal cancer
|
|
pezzstocks
|
16 |
5.1K |
10 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
16
|
5.1K
|
10
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: FDA advises regulatory pathway for PromarkerD in US
|
|
pezzstocks
|
50 |
15K |
4 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
50
|
15K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: FDA advises regulatory pathway for PromarkerD in US
|
|
pezzstocks
|
50 |
15K |
4 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
50
|
15K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: FDA advises regulatory pathway for PromarkerD in US
|
|
pezzstocks
|
50 |
15K |
1 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
50
|
15K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: FDA advises regulatory pathway for PromarkerD in US
|
|
pezzstocks
|
50 |
15K |
4 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
50
|
15K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: PromarkerD distribution network expands to Britain
|
|
pezzstocks
|
5 |
2.0K |
3 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
5
|
2.0K
|
3
|
|
ASX - By Stock
|
SOV |
Re:
Ann: SOV announces Capital Raising and National Expansion
|
|
pezzstocks
|
21 |
11K |
0 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
21
|
11K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: PromarkerD outperforms standard of care tests for DKD
|
|
pezzstocks
|
14 |
6.1K |
4 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
14
|
6.1K
|
4
|
|
ASX - By Stock
|
ABB |
Re:
is ABB a tenbagger in the making?
|
|
pezzstocks
|
3 |
2.8K |
3 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
3
|
2.8K
|
3
|
|
ASX - By Stock
|
ABB |
Re:
Ann: Share Purchase Plan Offer Booklet
|
|
pezzstocks
|
84 |
33K |
0 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
84
|
33K
|
0
|
|
ASX - By Stock
|
ABB |
Re:
Ann: Share Purchase Plan Offer Booklet
|
|
pezzstocks
|
84 |
33K |
0 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
84
|
33K
|
0
|
|
ASX - By Stock
|
ABB |
Re:
Ann: Share Purchase Plan Offer Booklet
|
|
pezzstocks
|
84 |
33K |
1 |
15/09/21 |
15/09/21 |
ASX - By Stock
|
84
|
33K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
5 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
322
|
93K
|
5
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
4 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
322
|
93K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
pezzstocks
|
47 |
13K |
2 |
14/07/21 |
14/07/21 |
ASX - By Stock
|
47
|
13K
|
2
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
pezzstocks
|
47 |
13K |
2 |
14/07/21 |
14/07/21 |
ASX - By Stock
|
47
|
13K
|
2
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
pezzstocks
|
47 |
13K |
6 |
14/07/21 |
14/07/21 |
ASX - By Stock
|
47
|
13K
|
6
|
|
ASX - By Stock
|
MPA |
Re:
IPO - Mad Paws Holdings Limited - 26 March 2021 #
|
|
pezzstocks
|
43 |
30K |
0 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
43
|
30K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
5 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
322
|
93K
|
5
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
5 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
322
|
93K
|
5
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
5 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
322
|
93K
|
5
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
5 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
322
|
93K
|
5
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
10 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
322
|
93K
|
10
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
4 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
322
|
93K
|
4
|
|
ASX - By Stock
|
CLU |
Re:
Ann: Half Year Results Presentation
|
|
pezzstocks
|
8 |
5.7K |
0 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
8
|
5.7K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
9 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
322
|
93K
|
9
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
1 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
322
|
93K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
8 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
322
|
93K
|
8
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
4 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
322
|
93K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
7 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
322
|
93K
|
7
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
6 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
322
|
93K
|
6
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
2 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
322
|
93K
|
2
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
3 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
322
|
93K
|
3
|
|
IPOs
|
|
Re:
Mad Paws IPO
|
|
pezzstocks
|
12 |
16K |
0 |
22/02/21 |
22/02/21 |
IPOs
|
12
|
16K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
7 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
322
|
93K
|
7
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
9 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
322
|
93K
|
9
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
3 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
322
|
93K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
2 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
322
|
93K
|
2
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
3 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
322
|
93K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
5 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
322
|
93K
|
5
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
4 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
322
|
93K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Response to Price Query
|
|
pezzstocks
|
5 |
2.3K |
8 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
5
|
2.3K
|
8
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
15 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
322
|
93K
|
15
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
7 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
322
|
93K
|
7
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
pezzstocks
|
322 |
93K |
9 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
322
|
93K
|
9
|
|